https://www.selleckchem.com/pr....oducts/Decitabine.ht
f pregnant women with active IBD. Controversies existed surrounding the use of hematocrit to guide early fluid therapy in acute pancreatitis (AP). The association between hematocrit, early fluid therapy, and clinical outcomes in ward AP patients needs to be investigated. Data from prospectively maintained AP database and retrospectively collected details of fluid therapy were analyzed. Patients were stratified into three groups Group 1, hematocrit 44% both at admission and at 24 h thereafter; Group 2 regardless of admission leve
Beğen
Yorum Yap
Paylaş
